Dyrness Albert D. (CIK 0001664801)

Latest company ownership

Shares held
4,537
Last filed at
Dec 3, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 30, 2023 May 31, 2023 Sonnet BioTherapeutics Holdings, Inc. Director Buy 91.3 +23,255 407.48% $10.9K
Jun 11, 2020 Jun 12, 2020 Sonnet BioTherapeutics Holdings, Inc. Director Buy 90.0 +2,409 94.21% $9.7K